News | Cath Lab | April 25, 2022

NewYork-Presbyterian Hudson Valley Hospital Launches Interventional Cardiology Program and Opens State-of-the-Art Cardiac Catheterization Lab

The new interventional cardiology program will provide advanced cardiac intervention services, expanding access to the hospital’s team of leading specialists and expert care.
 

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital


April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology program and the opening of its new cardiac catheterization laboratory, designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region.

“NewYork-Presbyterian Hudson Valley Hospital and NewYork-Presbyterian Medical Group Hudson Valley cardiologists have been caring for our community’s hearts for decades,” said Stacey Petrower, president of NewYork-Presbyterian Hudson Valley Hospital. “We pride ourselves on serving our community, and are pleased to now be providing emergent life-saving intervention, in addition to diagnostic and preventive medical procedures, close to home.”

Dr. Giora Weisz
Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons.

“We look forward to further improving the cardiac care for residents of our surrounding communities and providing comprehensive on-site care for patients already treated at our hospital,” said Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons. “When it comes to cardiac emergencies, time is muscle. Having a catheterization lab close to home means patients will have speedier access to expert care, and that leads to better outcomes, especially for those experiencing a life-threatening event such as a heart attack.”

The interventional cardiology program provides a variety of emergent procedures, including cardiac angioplasty to improve blood flow in narrow or blocked arteries for patients experiencing a heart attack or chest pain. Advanced cardiac services include diagnostic cardiac catheterization (a procedure in which a catheter is guided through a blood vessel in the heart to diagnose certain heart conditions) and minimally invasive procedures to open clogged arteries. These include percutaneous coronary intervention (PCI, also known as ‘balloon and stent procedure’) and endovascular peripheral arterial revascularization, as well as electrophysiology (EP) procedure services to restore heart rhythms. The interventional cardiology program is equipped with the most up to date, state-of-the-art equipment including novel catheters to image the blood vessels from the inside. Additionally, physicians provide pacemaker and defibrillator implantation for treatment of arrhythmias.

NewYork-Presbyterian Hudson Valley Hospital’s interventional cardiology program will be open for emergent cases 24 hours a day, seven days a week, and will have a structured schedule for diagnostic and non-emergent procedures. Patients who may require cardiac surgery will have easy access to surgeons at NewYork-Presbyterian/Columbia University Irving Medical Center, establishing seamless team-oriented continuity of care.

The 8,500-square-foot facility was designed in collaboration with Jeffrey Berman Architect, OLA Consulting Engineers and Severud Associates, and is part of a broader initiative to enhance cardiac services across NewYork-Presbyterian's health system.

For more information: https://www.nyp.org/hudsonvalley


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now